نتایج جستجو برای: hydroxymethylglutaryl coenzyme a reductase

تعداد نتایج: 13445218  

Journal: :European heart journal 2013
Bolli Thorsson Laufey Steingrimsdottir Sigrun Halldorsdottir Karl Andersen Gunnar Sigurdsson Thor Aspelund Vilmundur Gudnason

Introduction In a recent report by Farzadfar et al. on global trends in serum total cholesterol (TC), it is suggested that HMG-CoA reductase inhibitors (statins) are important for lowering of average TC in high-income countries and that statin use is a likely driver of the polarized trend in average TC seen between lowand high-income countries. On the other hand, our results show that statins a...

Journal: :British journal of clinical pharmacology 2001
P R Jackson E J Wallis I U Haq L E Ramsay

AIMS Increasingly HMG CoA reductase inhibitors (statins) are being used for primary prevention of vascular disease in patients with a raised cholesterol but at low absolute risk of coronary heart disease (CHD). This study uses clinical trial results to explore the limits of absolute safety for statin use in such patients. METHODS The major placebo controlled statin outcome trials were identif...

Journal: :Zeitschrift fur Naturforschung. Section C, Biosciences 1981
D Berg W Draber H von Hugo W Hummel D Mayer

Clotrimazole and triadimefon are known as potent inhibitors of ergosterol synthesis in pathogenic yeast and fungi, respectively. As their mode of action generally the inhibition of sterol desmethylation reactions is accepted. We report about a second effect, a "feed-back" inhibition of 3-hydroxy-3-methyl-glutaryl (HMG)-CoA-reductase by accumulation of ergosterol precursors. Addition of lanoster...

Journal: :Chemical communications 2013
Adi Haber Amona Abu-Younis Ali Michael Aviram Zeev Gross

The corrole-based catalytic antioxidant reduced the cholesterol biosynthesis ability of macrophages, harvested from mice treated with it. and a non-redox active analogue of it affect the committed step of the biosynthetic pathway--the HMG-CoA reductase catalysed reaction--by acting as allosteric inhibitors of this key enzyme.

Journal: :Molecular medicine reports 2012
Xue-Zhong Zhao Xu-Wen Li Yong-Ri Jin Xiao-Feng Yu Shao-Chun Qu Da-Yuan Sui

Kaempferide-7-O-(4''-O-acetylrhamnosyl)-3-O-rutinoside (A-F-B) is a novel flavonoid which is extracted from the leaves of Actinidia kolomikta. The aim of this study was to investigate the hypolipidemic effects of A-F-B in hyperlipidemic rats induced by a high-fat diet. Male Wistar rats were randomly divided into six groups: normal diet group, high...

Journal: :Journal of lipid research 1988
H J Kempen J F Glatz J A Gevers Leuven H A van der Voort M B Katan

The power of serum lathosterol concentration as an indicator of whole-body cholesterol synthesis was investigated in 47 human volunteers consuming two diets differing in fatty acid composition. The cholesterol balance (fecal excretion of neutral and acid steroids minus cholesterol intake) was strongly correlated with the serum level of total (free plus esterified) lathosterol and also with the ...

Journal: :The Annals of pharmacotherapy 1995
I Hsu S A Spinler N E Johnson

OBJECTIVE To evaluate the comparative efficacy and safety of the 4 currently available hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, fluvastatin, lovastatin, pravastatin, and simvastatin, in the treatment of primary hypercholesterolemia. DATA SOURCES English-language clinical studies, abstracts, and review articles identified from MEDLINE searches and bibliographies of iden...

Journal: :The Journal of biological chemistry 1973
P A Edwards

The existence of a circadian rhythm of activity of the hepatic microsomal enzyme, /3-hydroxy-P-methylglutaryl coenzyme A reductase (/3-hydroxy-p-methylglutaryl-CoA reductase, EC 1.1.1.34), is well established. This rhythm was abolished after adrenalectomy; the resulting reductase activity was low and essentially constant at a level approximating that of intact rats killed at the nadir of their ...

Journal: :Blood purification 2008
Abdelkarim Waness Sami Bahlas Saad Al Shohaib

Simvastatin is one of the most commonly prescribed CoA reductase inhibitors. The safety profile of this drug has been widely discussed in the medical and consumer advocacy communities. Like other statins, simvastatin can cause a serious and potentially life-threatening complication: rhabdomyolysis. We describe a case of simvastatin-induced rhabdomyolysis complicated by acute renal failure requi...

2015
C Pichardo–Almarza L Metcalf A Finkelstein V Diaz-Zuccarini

More than 100,000 people have participated in controlled trials of statins (lowering cholesterol drugs) since the introduction of lovastatin in the 1980s. Meta-analyses of this data have shown that statins have a beneficial effect on treated groups compared to control groups, reducing cardiovascular risk. Inhibiting the HMG-CoA reductase in the liver, statins can reduce cholesterol levels, thus...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید